LEVODOPA-CARBIDOPA CR
LEVODOPA-CARBIDOPA CR
Dormant
DIN Number
02421496
Drug Class
Human
Market Date
Mar 19, 2014
Company
HC
Pharmascience Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02421496
AIG Number0210315004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:36.16
Health Canada Classification
ACTIVE INGREDIENTS (2)
CARBIDOPAActive
Strength: 50 MG
Monograph: CARBIDOPA
LEVODOPAActive
Strength: 200 MG
Monograph: LEVODOPA